Related Experiment Video
Updated: May 18, 2026

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
Published on: August 2, 2016
Controlled release of doxorubicin from pH-responsive microgels
Mahrokh Dadsetan1, K Efua Taylor, Chun Yong
1Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN 55905, USA.
pH-responsive microgels made from oligo(polyethylene glycol) fumarate (OPF) and sodium methacrylate (SMA) efficiently deliver doxorubicin (DOX). These microgels enhance anti-tumor activity and reduce toxicity by controlling drug release based on pH and ionic strength.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Nanotechnology
Background:
- Stimuli-responsive hydrogels offer targeted drug delivery solutions by responding to physiological cues like pH and temperature.
- Doxorubicin (DOX) is a potent anti-cancer drug, but its systemic toxicity necessitates controlled delivery strategies.
- Optimizing anti-tumor efficacy while minimizing side effects is crucial for effective cancer chemotherapy.
Purpose of the Study:
- To develop pH-responsive microgels for enhanced doxorubicin (DOX) delivery.
- To investigate the influence of formulation parameters on microgel properties and drug release kinetics.
- To evaluate the anti-tumor activity of DOX delivered via the developed microgels.
Main Methods:
- Fabrication of pH-responsive microgels using a copolymer of oligo(polyethylene glycol) fumarate (OPF) and sodium methacrylate (SMA).
- Characterization of microgel charge, pH, and ionic strength sensitivity.
- Loading and in vitro release studies of DOX from the microgels.
- Development of a mathematical model to analyze DOX release profiles.
- Assessment of anti-tumor activity using a human chordoma cell line.
Main Results:
- OPF-SMA microgels demonstrated pH and ionic strength sensitivity, with charge density correlating to SMA concentration.
- Efficient loading and controlled release of DOX via an ion-exchange mechanism were achieved.
- DOX release kinetics were modulated by solution pH and ionic strength.
- A phenomenological model showed a linear correlation between maximum DOX release and SMA concentration.
- OPF-SMA microgels prolonged the cytotoxic effect of DOX against human chordoma cells.
Conclusions:
- OPF-SMA microgels represent a promising platform for pH-triggered, controlled doxorubicin delivery.
- The developed microgels can potentially improve anti-tumor efficacy and reduce systemic toxicity of DOX.
- The study provides a quantitative understanding of DOX release and its correlation with microgel formulation.
Related Concept Videos
Modified-Release Drug Delivery Systems: Stimuli-Activated
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Rate-Programmed I

